BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18328754)

  • 1. The importance of the domain of applicability in QSAR modeling.
    Weaver S; Gleeson MP
    J Mol Graph Model; 2008 Jun; 26(8):1315-26. PubMed ID: 18328754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationship modeling of the toxicity of organothiophosphate pesticides to Daphnia magna and Cyprinus carpio.
    Zvinavashe E; Du T; Griff T; van den Berg HH; Soffers AE; Vervoort J; Murk AJ; Rietjens IM
    Chemosphere; 2009 Jun; 75(11):1531-8. PubMed ID: 19376559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
    Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
    J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR study of selective ligands for the thyroid hormone receptor beta.
    Liu H; Gramatica P
    Bioorg Med Chem; 2007 Aug; 15(15):5251-61. PubMed ID: 17524652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR modeling using automatically updating correction libraries: application to a human plasma protein binding model.
    Rodgers SL; Davis AM; Tomkinson NP; van de Waterbeemd H
    J Chem Inf Model; 2007; 47(6):2401-7. PubMed ID: 17887744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stepwise approach for defining the applicability domain of SAR and QSAR models.
    Dimitrov S; Dimitrova G; Pavlov T; Dimitrova N; Patlewicz G; Niemela J; Mekenyan O
    J Chem Inf Model; 2005; 45(4):839-49. PubMed ID: 16045276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a chirality-sensitive flexibility descriptor for 3+3D-QSAR.
    Dervarics M; Otvös F; Martinek TA
    J Chem Inf Model; 2006; 46(3):1431-8. PubMed ID: 16711763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting physical properties of emerging compounds with limited physical and chemical data: QSAR model uncertainty and applicability to military munitions.
    Bennett ER; Clausen J; Linkov E; Linkov I
    Chemosphere; 2009 Nov; 77(10):1412-8. PubMed ID: 19793608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the schiff base applicability domain for skin sensitization.
    Roberts DW; Aptula AO; Patlewicz G
    Chem Res Toxicol; 2006 Sep; 19(9):1228-33. PubMed ID: 16978028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K; Roy PP
    Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of DEMETRA individual QSARs with an index for evaluation of uncertainty.
    Porcelli C; Roncaglioni A; Chana A; Benfenati E
    Chemosphere; 2008 May; 71(10):1845-52. PubMed ID: 18384837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.
    Hudelson MG; Ketkar NS; Holder LB; Carlson TJ; Peng CC; Waldher BJ; Jones JP
    J Med Chem; 2008 Feb; 51(3):648-54. PubMed ID: 18211009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability domains for classification problems: Benchmarking of distance to models for Ames mutagenicity set.
    Sushko I; Novotarskyi S; Körner R; Pandey AK; Cherkasov A; Li J; Gramatica P; Hansen K; Schroeter T; Müller KR; Xi L; Liu H; Yao X; Öberg T; Hormozdiari F; Dao P; Sahinalp C; Todeschini R; Polishchuk P; Artemenko A; Kuz'min V; Martin TM; Young DM; Fourches D; Muratov E; Tropsha A; Baskin I; Horvath D; Marcou G; Muller C; Varnek A; Prokopenko VV; Tetko IV
    J Chem Inf Model; 2010 Dec; 50(12):2094-111. PubMed ID: 21033656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.